Suppr超能文献

脂肪酸合酶和载脂蛋白 B 受体突变导致的家族性甲状腺功能减退症。

A family with hypothyroidism caused by fatty acid synthase and apolipoprotein B receptor mutations.

机构信息

Department of Oncology, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China.

Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.

出版信息

Mol Med Rep. 2018 Dec;18(6):4904-4912. doi: 10.3892/mmr.2018.9499. Epub 2018 Sep 20.

Abstract

Hypothyroidism is a disease with a genetic component. The present study aimed to identify the potential causative gene mutation in a family with hypothyroidism and to investigate its potential pathology. DNA was extracted from the affected individual and his parents, maternal aunt and maternal grandmother. Whole exome sequencing was used to examine their exomes. The potential causative genes that may have an autosomal dominant mode of inheritance were selected after variant calling and filtering. Bioinformatics analysis was utilized to predict the deleteriousness of the identified variants, and multiple sequence alignment and conserved protein domain analyses were performed using online software. Finally, Sanger sequencing was used to validate the identified variants. In the present study, a total of 50 variants were screened based on the autosomal dominant mode of inheritance. Two variants, the fatty acid synthase (FASN) and apolipoprotein B receptor (APOBR) genes, were further analyzed, as they were highly associated with hypothyroidism. Genotyping results revealed that two mutations, c.G7192T (p.A2398S) in the FASN gene and c.C1883G (p.T628R) in the APOBR gene, were fully co‑segregated with established hypothyroidism phenotypes in the family. These mutations were located in the conserved α/β‑hydrolase fold and Na+/Ca2+ exchanger superfamily domain of FASN and APOBR, respectively. In conclusion, the present study demonstrated that the FASN c.G7192T and APOBR c.C1883G mutations may be the potential causative variants in this Chinese hypothyroidism pedigree.

摘要

甲状腺功能减退症是一种具有遗传成分的疾病。本研究旨在鉴定一个甲状腺功能减退症家族的潜在致病基因突变,并探讨其潜在的病理学。从受影响的个体及其父母、姨母和祖母中提取 DNA。使用外显子组测序来检查他们的外显子。在进行变异调用和过滤后,选择可能具有常染色体显性遗传模式的潜在致病基因。利用生物信息学分析预测鉴定变异的有害性,并使用在线软件进行多序列比对和保守蛋白结构域分析。最后,使用 Sanger 测序验证鉴定的变体。在本研究中,根据常染色体显性遗传模式共筛选了 50 个变体。进一步分析了脂肪酸合酶(FASN)和载脂蛋白 B 受体(APOBR)基因的两个变体,因为它们与甲状腺功能减退症高度相关。基因分型结果显示,FASN 基因中的 c.G7192T(p.A2398S)和 APOBR 基因中的 c.C1883G(p.T628R)两个突变与家族中已确立的甲状腺功能减退症表型完全共分离。这些突变分别位于 FASN 和 APOBR 的保守α/β-水解酶折叠和 Na+/Ca2+交换超家族结构域。总之,本研究表明 FASN c.G7192T 和 APOBR c.C1883G 突变可能是这个中国甲状腺功能减退症家系的潜在致病突变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9d/6236273/9309b1272502/MMR-18-06-4904-g00.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验